Pfizer to acquire 8.1% share in French firm Valneva
Pfizer intends to commence the Phase III clinical trial of the vaccine in the third quarter of this year.
Analysis
Latest in
Analysis
Machine learning hiring levels in the pharmaceutical industry rose in May 2022
We've analysed hiring patterns using data from GlobalData
By
North America’s pharma industry IT hiring activity drops 4.3% in May 2022
North America witnessed a 4.3% drop in IT hiring activity in the pharma industry in May 2022 when compared with…
By
Magazine: Continuous manufacturing cautiously builds on hype
In this issue: We check whether continuous manufacturing is building on its hype, the access to CAR-T therapies in Central…
By
FDI in pharmaceuticals: The state of play
The pharmaceutical industry suffered a dip in FDI in 2020 as the Covid-19 pandemic hit, but did any countries manage…
By
IoT hiring levels in the pharmaceutical industry rose in May 2022
We've analysed hiring patterns using data from GlobalData
By
Data analytics hiring levels in the pharmaceutical industry dropped in May 2022
We've analysed hiring patterns using data from GlobalData
By
CMO Moves: Regulatory catalysts for drug manufacturing-March
Pharmaceutical Technology does a roundup of regulatory decisions in recent months that impact drugs and the CMOs enlisted to manufacture…
By